Discover how we’re moving from sick-care to well-care
When did healthcare become about treating sickness rather than maintaining health? Now is the time to ensure we aren’t just making people better, but helping them stay well. At Janssen EMEA, we’re on a mission: to move from an era of sick-care to well-care. We want to see a future of disease prevention rather than intervention, a future where disease is a thing of the past, and ultimately a world where patients are people with their health treated as a whole.
Mental Health 365 means to me…
Mental health is health. Our commitment to view mental health on parity with healthcare is demonstrated through our commitment to mental health yearlong. In our awareness initiative Mental Health 365 means to me we show our commitment to support mental health throughout the year. Aligned with our Dawning campaign, we believe in ensuring that our mental health is maintained rather than trying to fix it after it is broken. Through this campaign we hope to inspire others to commit to tackle mental health issues and have open conversations around mental health.
Our Dawning of the Well-Care Era episodes touch on important topics in healthcare such as this, and more are coming soon! Stay tuned to see experts discuss the growing and complex mental health crisis which requires a global response including support from pharma to identify and pursue potential solutions. Topics include issues around stigma and early intervention, prevention and access to care.
Discover more about our commitment to tackling mental health issues below.
Explore our the Dawning of a Well-Care Era episodes
MEET THE SPEAKERS :
Company Group Chairman Janssen EMEA & Managing Director Janssen Pharmaceutica
An advocate for embracing change, Kris has led the region’s response to the increasing digitalisation of healthcare. Here he talks about the importance of connecting people and seeing healthcare not as a cost but as an investment. The future is unparalleled, he argues, in terms of what benefits it can bring, and if we’re able to keep society healthy by being proactive and managing our health ourselves, we will not only be happier and healthier but also have a new well-care system fit for the 21st Century.
Daniel De Schryver
Patient Engagement and Advocacy Lead Janssen EMEA
In this video Daniel discusses how we are changing the way we develop solutions, so that we no longer just work for patients but with them, as partners. He also talks about the ways in which healthcare has changed over the last decade and how as a company we need to help people manage their health proactively, and we need to think of patients not only as people living with conditions, but also as people who are at risk of developing conditions.
Vice President Customer & Digital Strategy, Janssen EMEA
The visionary and health tech enthusiast, talking about the exciting capabilities of developing digital health solutions, such as wearable tech, as part of a larger remote monitoring service. Discussing how we can connect data and analytics to existing consumer devices to create the next generation of healthcare solutions. What will this mean for empowering people in managing their own health and wellbeing before they get sick? She also discusses the realities we face when it comes to widespread public adoption: Is it realistic? Will we see enough long-term engagement?
Managing Director Germany, Janssen EMEA
As an advocate for the digitization of healthcare, Andreas understands the enormous potential that health data has to sustainably improve healthcare for all. However, he is also aware that people's health data is a highly personal asset that needs special protection. That is why he has long advocated for transparent and binding rules on how this data is collected and stored and what it can be used for and by whom. Andreas wants to help people understand that they can trust that their data will be appropriately collected, stored and used for their benefit. Andreas understands that, if used properly, data can help advance medical progress and ultimately benefit society.
General Manager, Janssen Turkey
A passionate advocate for health equity, she continues to challenge many of the systemic barriers we still see today, and in particular, the specific inequalities experienced by women. In this video, Demet explores the origins of gender discrimination and bias, with what that means to both women in need of healthcare, and those working within it. Demet also shares her views on what needs to change to ensure the equal representation of views, and in turn, speed up the progress of women’s equality.
Head of Government Affairs and Policy at Johnson & Johnson, Germany
In his first video, Hans-Christian explores some of the positives we can take from the pandemic, with governments, health systems and industry now better equipped to prepare for and tackle future public health emergencies. Hans-Christian also speaks to the role of society and how we need to act as a unified force to overcome global health risks. He believes that from the community action already seen, lasting positive changes will be made. In the second video, Hans-Christian goes onto talk about the possibilities of using personal data to help forecast where the next event might occur. Although, with the use of such information, comes the question of personal privacy. Hans-Christian however believes that by taking people on the journey, showing them what their information could do to improve healthcare, their trust can be earned.
VP Infectious Diseases and Vaccines, Commercial Strategy Lead, Janssen EMEA
As a leader in the field, Roz explores the importance of pandemic preparedness and ‘getting ahead of the curve’ to inform future decision making – viewing the pandemic as a ‘huge wake-up call’. She talks about the warning signals we have already seen, and the need for better preparation to minimise the impact of future disease outbreaks. In her second video, Roz goes on to highlight the need to rethink our approach to disease surveillance, which traditionally only starts once enough people with matching symptoms have all been formally diagnosed. She speaks about the opportunity to supplement existing surveillance with ‘internet epidemiology’ – a methodology that tracks our internet history to identify geographical locations where multiple people may be searching for information around specific symptoms.
Prof. Dr. med. Mazda Adli
Chief Physician, Fliedner Klinik Berlin, Professor and Specialist in Psychiatry and Psychotherapy
To explore how we can approach mental health as we move toward a well-care era, we welcome Dr Mazda Adli. In our first episode of the series, Dr Adli joins Martin Price of Janssen to discuss the importance of early intervention in mental health. Recognising how much of a difference early intervention can mean for mental health outcomes, what are the barriers, and how can we tackle them? In the second episode of the series Dr Adli and Martin Price discuss the importance of prevention, and consider some of the big societal trends that provide context to the rise of mental health problems. In the third episode of the series, it is access to care under the spotlight. Dr Adli and Martin Price consider the obstacles to equitable access to care, and what strategies could be employed to overcome them.
Vice President, Health Economics, Market Access & Reimbursement at Janssen
Martin Price is Vice President, Health Economics, Market Access & Reimbursement at Janssen and is a passionate mental health advocate. In the first episode of our series on mental health, Martin is joined by Dr Mazda Adli to discuss the importance of early intervention in mental health, specifically considering issues around stigma, parity of esteem and health literacy. Martin and Dr Adli reunite for the second episode in our mental health series but this time are talking about prevention in mental health. What do we need to consider about nature versus nurture and the way modern society is structured when looking at preventative measures? In the third episode of the series, it is access to care under the spotlight. Dr Adli and Martin Price consider the obstacles to equitable access to care, and what strategies could be employed to overcome them.